
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Obesity is on the rise and hard to treat. Whenever possible, you, your patient, and the family should face the problem early and deal with it before it assumes awesome proportions. For a moderately obese child, not gaining for a while may be all that's needed.






